The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinoma (Q37582648)
Jump to navigation
Jump to search
scientific article published on August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinoma |
scientific article published on August 2009 |
Statements
1 reference
The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinoma (English)
1 reference
Jessica M Clement
1 reference
David F McDermott
1 reference
1 August 2009
1 reference
1 reference
7
1 reference
2
1 reference
E7-9
1 reference
Identifiers
1 reference
1 reference